Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: jef saunders who wrote (7817)	10/7/2001 11:57:09 PM
From: TheBusDriver	Respond to of 14101

as someone posted a while back. It is because I retook a position in the company.......He made a smart move<grin> Wayne PS I still have the stock, DMX will recover.

To: jef saunders who wrote (7817)	10/8/2001 12:49:48 PM
From: bdalarge	Read Replies (2) \| Respond to of 14101

I fully agree with you that the 4 approvals is ultimately a very good thing. However, I believe that this again is a classic example of how Dimethaid set the wrong expectations and as a result are suffering the consequences along with the average retail investor. You can not continually go around telling your small investor following things ( I am referring to the proclamation that we would have a EU partner prior to approvals) and then not have them happen. The average investor is not sophisticated enough to read between the lines of what it really means to have 4 more countries on board. It is very easy for us to say that this was pout of Dimethaid's control. However, we seem to say that alot. What is in their control is relaying appropriate information to shareholders in a timely and efficient fashion. I have said this before and I will say it again. The only thing that matters for this company is delivering on FDA approvals. If they get it and I believe they will then the world will take notice and the long term shareholders will be truly rewarded. If however there is a hiccup in the FDA process and an NR is released to that effect I have no doubt we will hammered on the open markets. Sorry for the lengthy dissertation. Just reflecting on the last couple of weeks.